Ya Liu

Ya Liu

hospital of chengdu university of traditional chinese medicine

Affiliated withhospital of chengdu university of traditional chinese medicine

Research Area

Biography

Dr. Yanbiao Liu is a Full Professor in the College of Environmental Science and Engineering, Donghua University in Shanghai, China. He received his Ph.D. degree in Environmental Science from Shanghai Jiao Tong University, China. He pursued his postdoctoral training at the NUS Environmental Research Institute (NERI) of National University of Singapore (NUS) during 2012−2016. He joined Donghua University as a Professor since 2017. His current research interests are engineering functional nanomaterials for environmental applications.

JoVE Journal Publications

ArticleTotal : 1
Year
Acupoint Needle-Embedding Combined with Ironing Therapy for Postoperative Pain After Anal Surgery
Publication title

Cited by 1

2023

Other Publications

Article
Year
[Effect of Shenqi compound on PTEN/PI3K signal transduction in GK rats with diabetes mellitus macroangiopathy].

Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine| PubMed ID: 20815283

2010
2015
2016
Exploration of the Effect and Mechanism of ShenQi Compound in a Spontaneous Diabetic Rat Model.

Endocrine, metabolic & immune disorders drug targets| PubMed ID: 30799801

2019
2019
Exploring the Protective Effect of ShenQi Compound on Skeletal Muscle in Diabetic Macrovasculopathy Mice.

Endocrine, metabolic & immune disorders drug targets| PubMed ID: 32096754

2020
2020
2020
2020
Network Pharmacology-Based Identification of the Mechanisms of Shen-Qi Compound Formula in Treating Diabetes Mellitus.

Evidence-based complementary and alternative medicine : eCAM| PubMed ID: 32595730

2020
2020
2021
2020
2021
Exploration of SQC Formula Effect on Type 2 Diabetes Mellitus by Whole Transcriptome Profile in Rats.

Endocrine, metabolic & immune disorders drug targets| PubMed ID: 33632114

2021
2021
2021
Shenqi compound ameliorates type-2 diabetes mellitus by modulating the gut microbiota and metabolites.

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences| PubMed ID: 35219959

2022
Emodin Alleviates High-Glucose-Induced Pancreatic -Cell Pyroptosis by Inhibiting NLRP3/GSDMD Signaling.

Evidence-based complementary and alternative medicine : eCAM| PubMed ID: 35265148

2022
2022
2022
2022
2022
2023
2023